Mark has been a partner at Bird & Bird since May 2007 and his practice focuses on pan-European patent litigation in various fields of technology. He has a PhD in organic chemistry, which leads him naturally to specialise in areas such as pharmaceuticals and the chemical industry. He is the lead partner for one of the world's largest generic pharmaceutical companies.
In the past few years Mark has been involved in several actions before the English courts and has coordinated many pan-European patent disputes. Recently, he has advised a generic pharmaceutical company in bringing the first pan-European declaration of non-infringement in the High Court. He has also advised on regulatory and competition law issues. Mark also works for the food industry for clients such as Mondelez for whom he advises on patent issues relating to food processing and in the developing field of functional foods. He also specialises in intellectual property issues surrounding the clean and renewable energy sector. He has advised several clients in relation to patent issues in this field including in relation to carbon capture plants and high altitude wind turbines.
He also has experience in drafting intellectual property agreements and licences, conducting intellectual property audits, preparing freedom to operate opinions, EPO oppositions and advising on intellectual property aspects of international corporate transactions including IPOs.
Chambers UK 2012 noted, 'Mark Hilton advised a big pharmaceutical company on a major patent action in the High Court and the Court of Appeal, a reflection of his expertise and, according to sources, 'the depth of his analysis and considerable scientific understanding.''
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Shop.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.